港股龙头回购持续发力,医渡科技一月内15次回购,机构看好其AI医疗布局
Zhi Tong Cai Jing·2026-02-16 07:27

Group 1 - The core viewpoint of the article highlights the ongoing share buyback trend in the Hong Kong stock market since 2026, with leading companies like Yidu Tech (02158) actively participating to demonstrate confidence in their intrinsic value and future development [1] Group 2 - On February 16, Yidu Tech announced a share buyback of 404,000 shares at approximately HKD 5.91 per share, costing nearly HKD 2.4 million, marking its 15th buyback since 2026 and totaling close to HKD 67 million in expenditures [1] - The buyback activity of Yidu Tech is characterized by "high frequency and steady strength," having completed 15 buybacks in less than a month since the first buyback on January 26 [1] - Yidu Tech's business prospects have been positively impacted by recent developments, including the successful selection of a multimodal AI database project for gastrointestinal tumor diagnosis in collaboration with Huazhong University of Science and Technology [1] - Citigroup maintained a "buy" rating for Yidu Tech in February and raised its target price to HKD 11, reflecting institutional recognition of the company's growth potential [1]

YIDU TECH-港股龙头回购持续发力,医渡科技一月内15次回购,机构看好其AI医疗布局 - Reportify